FRME Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
FRME is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock has some constructive technical support and a favorable analyst target revision, but the overall setup is mixed: insiders are selling, there is no recent news catalyst, no strong proprietary buy signal, and the options sentiment is only mildly bullish rather than compelling. Best call: hold and wait for a clearer pullback or stronger confirmation before committing capital.
FRME’s short-term trend is mildly bullish. Price closed at 43.99, above the previous close, while the moving averages are aligned positively with SMA_5 > SMA_20 > SMA_200, which supports an uptrend. MACD histogram is positive at 0.231, but it is contracting, suggesting momentum is fading somewhat. RSI_6 at 60.384 is neutral-to-bullish and not stretched. Key levels to watch are pivot 42.66, resistance at 44.199 and 45.151, and support at 41.121 and 40.169. Overall, the chart is constructive but not a high-conviction breakout setup.
["Piper Sandler raised its price target to $51 from $49 and maintained an Overweight rating.", "Technical trend remains bullish with SMA_5 > SMA_20 > SMA_200.", "Price is trading above the pivot level, supporting near-term stability.", "Options open interest tilt is bullish with a 0.41 put-call ratio."]
["No news in the recent week, so there is no fresh event-driven catalyst.", "Insiders are selling, and selling activity increased 156.41% over the last month.", "Hedge funds are neutral with no significant trading trends over the last quarter.", "AI Stock Picker and SwingMax both show no signal today.", "Stock trend model suggests only a 0.67% chance of gain over the next month, indicating limited near-term upside confidence."]
Latest quarter financials were not available due to a data error, so I cannot confirm the company’s most recent seasonal results or growth trends from the provided snapshot.
The latest analyst trend is positive: on 2026-06-26, Piper Sandler lifted the price target to $51 from $49 and kept an Overweight rating. That is a constructive Wall Street view, but it is only one update and does not override the mixed insider-selling and lack of catalyst picture. Overall pros view: favorable valuation confidence and upside target revision; cons view: no strong momentum signal, no fresh news, and insiders selling.
